SB 535 formally paves the way for health care clinics to become 'experimental treatment centers' that can provide drugs still in development to willing patients.
Tim Friede might be the world's most snakebit person—and his antibodies could hold the key to a truly universal snake antivenom.
In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month period than those on a placebo.
About one in five Americans has a genetic risk for a dangerous type of cholesterol.
Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.
New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected with the deadliest species of Ebola.
Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose weight—without the nauseating symptoms now commonly seen with GLP-1 drugs.
In a new study on mice, an experimental antibody treatment reduced the lingering after-effects of head injuries.
Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.
New research suggests that inhaled xenon gas can help protect the brains of those with Alzheimer's disease.
A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like Ozempic.
Demi Moore, Margaret Qualley, and Dennis Quaid star in a new body horror film that won Best Screenplay at this year's Cannes Film Festival.
Researchers were able to reverse anorexia symptoms in mice by increasing levels of a peptide important to stimulating hunger.
